Form D — Maxymune Therapeutics, Inc.
0002058052-26-000004 · filed Jun 3, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $4,500,000
- Total sold
- $2,675,000
- Minimum investment
- $10,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Maxymune Therapeutics, Inc.
- CIK
- 2058052
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 95 MAIN ST.
LOS ALTOS, CA 94022 - Phone
- 650-892-1942
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Gordon Ringold · Executive OfficerTruckee, CA Find on LinkedIn ↗
-
Neil Solomons · DirectorVictoria, A1 Find on LinkedIn ↗
-
Tatjana Naranda · Executive OfficerLos Altos, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗